BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11561119)

  • 21. Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes.
    Brito-Zerón P; Retamozo S; Gandía M; Akasbi M; Pérez-De-Lis M; Diaz-Lagares C; Bosch X; Bové A; Pérez-Alvarez R; Soto-Cárdenas MJ; Sisó A; Ramos-Casals M
    J Autoimmun; 2012 Aug; 39(1-2):43-8. PubMed ID: 22297146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features.
    Rosas J; Ramos-Casals M; Ena J; García-Carrasco M; Verdu J; Cervera R; Font J; Caballero O; Ingelmo M; Pascual E
    Rheumatology (Oxford); 2002 Jun; 41(6):670-5. PubMed ID: 12048294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
    De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
    Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.
    Jamin C; Lamour A; Pennec YL; Hirn M; Le Goff P; Youinou P
    Clin Exp Immunol; 1993 May; 92(2):245-50. PubMed ID: 7683586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cell-mediated immunity in patients with Sjogren's syndrome].
    Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
    Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
    Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
    Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sjögren's syndrome: an oligo-monoclonal B cell process.
    Tzioufas AG; Katsikis PD; Youinou PY; Moutsopoulos HM
    Clin Exp Rheumatol; 1990; 8 Suppl 5():17-21. PubMed ID: 1700939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low levels of heat shock proteins-60 and -65 autoantibodies in Sjögren's syndrome.
    Shovman O; Sherer Y; Gilbourd B; Gerli R; Bocci EB; delle Monache F; Luccioli F; Shoenfeld Y
    Isr Med Assoc J; 2005 Dec; 7(12):778-80. PubMed ID: 16382698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hepatitis B virus infection in Sjögren's syndrome. Prevalence and clinical significance in 603 patients.
    Marcos M; Alvarez F; Brito-Zerón P; Bove A; Perez-De-Lis M; Diaz-Lagares C; Sanchez-Tapias JM; Ramos-Casals M
    Autoimmun Rev; 2009 Jun; 8(7):616-20. PubMed ID: 19393197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome.
    Font J; García-Carrasco M; Ramos-Casals M; Aldea AI; Cervera R; Ingelmo M; Vives J; Yagüe J
    Rheumatology (Oxford); 2002 Sep; 41(9):1025-30. PubMed ID: 12209037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of RP105-lacking activated B cells in the peripheral blood and salivary glands in patients with Sjögren's syndrome.
    Kikuchi Y; Koarada S; Nakamura S; Yonemitsu N; Tada Y; Haruta Y; Morito F; Ohta A; Miyake K; Horiuchi T; Nagasawa K
    Clin Exp Rheumatol; 2008; 26(1):5-12. PubMed ID: 18328140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjögren's syndrome.
    Halse A; Wahren-Herlenius M; Jonsson R
    Clin Exp Immunol; 1999 Jan; 115(1):208-13. PubMed ID: 9933444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
    Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG
    Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.
    Jülich M; Kanne AM; Sehnert B; Budweiser S; Voll RE; Kollert F
    Clin Rheumatol; 2018 Sep; 37(9):2361-2366. PubMed ID: 29858711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum IgA against type 3 muscarinic acetylcholine receptor is a novel marker in diagnosis of Sjögren's syndrome.
    Li YN; Guo JP; He J; Liu X; Yin FR; Ding Y; Yao HH; Kang AJ; Li ZG
    Chin Med J (Engl); 2011 Aug; 124(16):2490-5. PubMed ID: 21933593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
    Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
    J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
    Suresh L; Malyavantham K; Shen L; Ambrus JL
    BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjögren's syndrome.
    Willeke P; Schotte H; Schlüter B; Erren M; Becker H; Dyong A; Mickholz E; Domschke W; Gaubitz M
    Ann Rheum Dis; 2003 Apr; 62(4):359-62. PubMed ID: 12634239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of interleukin 10 in Sjögren's syndrome; correlation with increased IgG1.
    Perrier S; Serre AF; Dubost JJ; Beaujon G; Plazonnet MP; Albuisson E; Sauvezie B
    J Rheumatol; 2000 Apr; 27(4):935-9. PubMed ID: 10782819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.